Tevogen Bio Holdings Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,446 | -26,275 | -21,598 | -15,871 | -10,367 |
| Depreciation Amortization | 59 | 509 | 423 | 396 | 105 |
| Accounts payable and accrued liabilities | 459 | -1,964 | -1,992 | -960 | -536 |
| Other Working Capital | -170 | -2,725 | -2,692 | -1,563 | -350 |
| Other Operating Activity | 2,365 | 18,126 | 15,712 | 11,499 | 7,839 |
| Operating Cash Flow | $-2,734 | $-12,329 | $-10,147 | $-6,498 | $-3,308 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -64 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-64 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000 | 3,400 | 3,400 | 3,400 | 2,000 |
| Common Stock Issued | 874 | 4,862 | 3,101 | N/A | N/A |
| Other Financing Activity | 0 | 3,400 | 3,400 | 2,500 | 2,000 |
| Financing Cash Flow | $2,874 | $11,662 | $9,901 | $5,900 | $4,000 |
| Beginning Cash Position | 552 | 1,283 | 1,283 | 1,283 | 1,283 |
| End Cash Position | 692 | 552 | 1,037 | 685 | 1,975 |
| Net Cash Flow | $140 | $-731 | $-246 | $-598 | $692 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,734 | -12,329 | -10,147 | -6,498 | -3,308 |
| Capital Expenditure | N/A | -64 | N/A | N/A | N/A |
| Free Cash Flow | -2,734 | -12,393 | -10,147 | -6,498 | -3,308 |